Advertisement

Journal of Child and Family Studies

, Volume 17, Issue 6, pp 839–852 | Cite as

Clinical and Non-Clinical Characteristics Associated with Medication Use Among Children with Serious Emotional Disturbance

  • Thomas W. Pavkov
  • Christine M. Walrath
Original Paper

Abstract

Our study explores the clinical and non-clinical characteristics associated with medication use among children with serious emotional disturbance who are referred into community-based family-driven system of care settings. Using data collected as part of the Comprehensive Community Mental Health Services for Children and Their Families Program initiative, our study provides results from analyses completed on 7,009 children and adolescents with serious emotional disturbance. Using both bivariate and multivariate statistical analyses, the researchers found that females entering systems of care were less likely to have received medication in the 6-months prior to entry, as were children of African-American and Native-American heritage compared to children from non-Hispanic White heritage. Children referred from mental health, child welfare or who were self-referred were more likely to use medications than those referred from juvenile justice. Children with histories of prior inpatient, outpatient, day treatment, or school-based services were between 2 and 4 times more likely to use medications than children without such histories. Children with family histories of mental illness and those who were Medicaid recipients were also more likely to use medications. Family income was also positively related to medication use and younger children were more likely to use medications than older children. Implications of the findings are discussed.

Keywords

Psychotropic medication Medication use Systems of care Child and adolescent mental health services 

Notes

Acknowledgments

This research was funded by the Center for Mental Health Services of the Substance Abuse and Mental Health Services Administration (280-99-8023, 280-00-8040). The children and families who participated in the ongoing collection of data made this research possible.

References

  1. American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.Google Scholar
  2. Bassarath, L. (2003). Medication strategies in childhood aggression: A review. Canadian Journal of Psychiatry, 48, 367–373.Google Scholar
  3. Bussing, R., Leon, C., Mason, D., & Sinha, K. (2003). Agreement between CASA parent reports and provider records of children’s ADHD services. Journal of Behavioral Health Services and Research, 30, 462–469.PubMedCrossRefGoogle Scholar
  4. Center for Mental Health Services. (2001). Annual Report to Congress on the Evaluation of the Comprehensive Community Mental Health Services for Children and Their Families Program. Atlanta, GA: ORC Macro International, Inc.Google Scholar
  5. Connor, D., Ozbayrak, K., & Harrison, R. (1998). Prevalence and patterns of psychotropic and anticonvulsant medication use in children and adolescents referred to residential treatment. Journal of the American Academy of Child and Adolescent Psychopharmacology, 8, 27–38.Google Scholar
  6. Epstein, M., & Cullinan, D. 1995. Personal, family, and service use characteristics of young people served by an interagency community-based system of care. Journal of Emotional and Behavioral Disorders, 3, 55–69.Google Scholar
  7. Gadow, K., (1997). An overview of three decades of research in pediatric psychopharmacologic epidemiology. Journal of Child and Adolescents Psychopharmacology, 7, 219–236.Google Scholar
  8. Goodwin, R., Gould, M., Blanco, C., & Olfson, M. (2001). Prescription of psychotropic medications to youth in office-based practice. Psychiatric Services, 52, 1081–1087.PubMedCrossRefGoogle Scholar
  9. Guevara, J., Lozano, P., Wickizer, T., Mell, L., & Gephart, H. (2002). Psychotropic medication use in a population of children who have attention-deficit/hyperactivity disorder. Pediatrics, 109, 733–739.PubMedCrossRefGoogle Scholar
  10. Hallfors, D. 1998. An examination of psychotropic drug treatment for children with serious emotional disturbance. Journal of Emotional and Behavioral Disorders, 6, 56–67.Google Scholar
  11. Hoagwood, K., Burns, B., Kiser, L., Ringeisen, H., & Schoenwald, S. (2000). Medication management of stimulants in pediatric practice settings: A national perspective. Journal of Developmental and Behavioral Pediatrics, 21, 322–331.PubMedCrossRefGoogle Scholar
  12. Holden, E., Friedman, R., & Santiago, R. (2001). Overview of the national evaluation of the comprehensive community mental health services for children and their families program. Journal of Emotional and Behavioral Disorders, 9, 4–12.CrossRefGoogle Scholar
  13. Jensen, P., Bhatara, V., & Vitiello, B. (1999). Psychoactive medication prescribing practices for U.S. children. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 557–565.PubMedCrossRefGoogle Scholar
  14. Jensen, P., Hoagwood, K., & Petti, T. (1996). Outcomes of mental health care for children and adolescents: II. Literature review and application of a comprehensive model. Journal of the American Academy of Child and Adolescent Psychiatry, 35, 1064–1077.PubMedGoogle Scholar
  15. Kelleher, K., Hohmann, A., & Larson, D. (1989). Prescription of psychotropics to children in office-based practice. American Journal of Diseases of Children, 143, 855–859.PubMedGoogle Scholar
  16. Leslie, L., Weckerly, J., Landsverk, J., Hough, R., Hurlburt, M., & Wood, P. (2003). Racial/ethnic differences in the use of psychotropic medications in high-risk children and adolescents. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1433–1442.PubMedCrossRefGoogle Scholar
  17. Lyons, J. (2000). A call for outcomes data: Psychopharmacology with children. Outcomes and Accountability Alert, 5, 1–13.Google Scholar
  18. MacIntyre, J., Carpinello, S., Zuber, M., & Fazio, M. (2004). Psychotropic medications prescribing for children and adolescents in New York’s public mental health system. Community Mental Health Journal, 40, 101–123.PubMedCrossRefGoogle Scholar
  19. Martin, A., Van Hoof, T., Stubbe, D., Sherwin, T., & Scahill, L. (2003). Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid Managed Care. Psychiatric Services, 54, 72–77.PubMedCrossRefGoogle Scholar
  20. Pumariega, A., Del Muno A., & Vance, B. (2002). Psychopharmacology in the context of systems of care. In: B. J. Burns & K. Hoagwood (Eds.), Community treatment for youth (pp. 277–300). New York: Oxford University Press.Google Scholar
  21. Rawal, P., Lyons, J., MacIntyre, J., & Hunter, J. (2004). Regional variation and clinical indicators of antipsychotic use in residential treatment: A four state comparison. Journal of Behavioral Health Services and Research, 31, 178–188.PubMedGoogle Scholar
  22. Shireman, T., Olson, B., & Dewan, N. (2002). Patterns of antidepressant use among children and adolescents. Psychiatric Services, 53, 1444–1450.PubMedCrossRefGoogle Scholar
  23. Vitiello, B. (2001). Psychopharmacology for young children: Clinical needs and research opportunities. Pediatrics, 108, 983–989.PubMedCrossRefGoogle Scholar
  24. Warner, L., Pottick, K., & Bilder, S. (2005). Clinical and organizational correlates of medication for youths in U.S. mental health services. Social Service Review, 79, 454–481.CrossRefGoogle Scholar
  25. Werry, J., & Aman, M. (1993). Practitioner’s guide to psychoactive drugs for children and adolescents. New York: Plenum.Google Scholar
  26. Zima, B., Bussing, G., Crecelius, A., Kaufman, A., & Belin, T. (1999). Psychotropic medication treatment patterns among school-aged children in foster care. Journal of Child and Adolescent Psychopharmacology, 9, 135–147.PubMedCrossRefGoogle Scholar
  27. Zito, J., Safer, D., DosReis, S., Gardner, J., Magder, L., Soeken, K., Boles, M., Lynch, F., & Riddle, M. (2003). Psychotropic practice patterns for youth: A 10-year perspective. Archives of Pediatric and Adolescent Medicine, 157, 17–25.Google Scholar
  28. Zito, J., Safer, D., DosReis, S., Gardner, J., Soeken, K., Boles, M., & Lynch, F. (2002). Rising prevalence of antidepressants among U.S. youths. Pediatrics, 109, 721–727.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  1. 1.Institute for Social and Policy ResearchPurdue University CalumetHammondUSA
  2. 2.Macro International, Inc.New YorkUSA

Personalised recommendations